![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 36, 25197-25200, September 3, 1999
§,
,
¶,
,
¶
From the
Department of Molecular Biology and
Biochemistry, Osaka University Medical School, Suita 565-0871, Japan,
the ¶ Takai Biotimer Project, ERATO, Japan Science and Technology
Corporation, c/o JCR Pharmaceuticals Co. Ltd., 2-2-10 Murotani,
Nishi-ku, Kobe 651-2241, Japan, and the ** Department of Virology II,
National Institute of Infectious Disease, Tokyo 162-8640, Japan
| |
ABSTRACT |
|---|
|
|
|---|
We have recently isolated a novel
actin filament-binding protein, named frabin. Frabin has one actin
filament-binding domain (ABD), one Dbl homology domain (DHD), first
pleckstrin homology domains (PHD) adjacent to DHD, one cysteine
rich-domain (CRD), and second PHD from the N terminus to the C
terminus in this order. Full-length frabin induces microspike formation
and c-Jun N-terminal kinase (JNK) activation. We found here that the
fragment of frabin containing DHD and first PHD stimulated guanine
nucleotide exchange of Cdc42Hs small G protein, but not that of RhoA or
Rac1 small G protein. However, this fragment of frabin did not induce
microspike formation, and ABD was additionally necessary for microspike
formation. Frabin having ABD was associated with the actin
cytoskeleton, whereas frabin lacking ABD was diffusely distributed in
the cytoplasm. In contrast, ABD was not necessary for JNK activation
but CRD and second PHD were additionally necessary for this activation. These results indicate that the association of frabin with the actin
cytoskeleton is essential for microspike formation but not for JNK
activation and that different domains of frabin are involved in
microspike formation and JNK activation through Cdc42 activation.
Dynamic reorganization of the actin cytoskeleton is implicated in
many cell functions, including cell shape change, adhesion, and
motility (for reviews, see Refs. 1-3). Evidence is accumulating that
the Rho family small GTP-binding proteins (G
proteins)1 are important
regulators of these actin-dependent cell functions (for
reviews, see Refs. 4-6). The Rho family consists of three major
subfamilies: the Cdc42, Rac, and Rho subfamilies (Cdc42, Rac, and Rho,
respectively). In fibroblasts, Cdc42 induces filopodium formation; Rac
induces lamellipodium and membrane ruffle formation; and Rho regulates
assembly of stress fibers and focal adhesions. In addition to these
functions, the Rho family members are involved in the regulation of
gene expression, cell growth, cell-cell adhesion, and cell motility
(4-6).
The Rho family members cycle between the GDP-bound inactive and
GTP-bound active forms (4-6). The conversion from the GDP-bound form
to the GTP-bound form is stimulated by a GDP/GTP exchange factor (GEF).
Many GEFs for the Rho family members have thus far been identified and
shown to share two conserved domains: a Dbl homology domain (DHD) of
about 250 amino acids (aa) and a pleckstrin homology domain (PHD) of
about 100 aa adjacent to DHD. We have recently isolated a novel actin
filament (F-actin)-binding protein, named frabin (7). Frabin has one
F-actin-binding domain (ABD), one DHD, first PHD adjacent to DHD, one
cysteine rich-domain (CRD), and second PHD from the N terminus to the C
terminus in this order. This domain structure of frabin is similar to
that of a GEF specific for Cdc42, FGD1, determined by positional
cloning to be the genetic locus responsible for faciogenital dysplasia
or Aarskog-Scott syndrome (8, 9), except that FGD1 lacks ABD but has a
proline-rich domain. Overexpression of frabin in Swiss 3T3 cells and
COS7 cells induces microspike formation and c-Jun N-terminal kinase
(JNK) activation, respectively, as described for Cdc42 and FGD1 (9). However, we had not examined whether frabin shows GEF activity on
Cdc42. In this study, we first examined this activity of frabin and
then the role of each domain of frabin in microspike formation and JNK activation.
Materials and Chemicals--
Lipid-modified RhoA, Rac1, and
Cdc42Hs were purified from the membrane fraction of Spodoptera
frugiperda cells transfected with baculovirus carrying the
respective cDNAs (10). Glutathione S-transferase
(GST)-Dbl and GST-Rho GDP dissociation inhibitor (GDI) were prepared as
described (10). The GST carrier of GST-Rho GDI was cleaved off from Rho
GDI by digestion with thrombin. Primary cultured rat hippocampal
neurons were prepared as described previously (11). A rabbit antiserum
against frabin was raised against GST-frabin-h (aa 1-208) described
below. This antiserum was affinity-purified with GST-frabin-h
covalently coupled to N-hydroxysuccinimide-activated Sepharose (Amersham Pharmacia Biotech, Ltd.) and used as an anti-frabin antibody. A monoclonal anti-Myc antibody was from American Type Culture
Collection (Manassas, VA). An anti-hemagglutinin (HA) antibody was
prepared as described previously (12). pSR Construction of Expression Vectors--
Eukaryotic and
prokaryotic expression vectors of frabin were constructed in pCMV-Myc
(11), pCMV-green fluorescent protein (GFP), and pGEX-KG (15) using
standard molecular biology methods (16). Various pCMV-Myc constructs of
frabin shown in Fig. 2A contained the following aa residues:
pCMV-Myc-frabin-a, aa 1-766 (full length); pCMV-Myc-frabin-b, aa
1-150; pCMV-Myc-frabin-c, aa 151-766; pCMV-Myc-frabin-d, aa 169-539;
and pCMV-Myc-frabin-e, aa 1-539. GST fusion constructs of frabin
contained the following aa residues: GST-frabin-h, aa 1-208; and
GST-frabin DH/PH, aa 169-539. pCMV-GFP was constructed by subcloning
the insert encoding the GFP of pEGFP-N1 (CLONTECH)
into pCMV5. pCMV-GFP-Frabin contained full-length frabin to express the
fusion protein with the C-terminal GFP. The pCMV-Myc and pCMV-GFP
constructs were transfected into COS7 cells using the DEAE-dextran
method (17). The GST fusion proteins were purified by use of
glutathione-Sepharose beads (Amersham Pharmacia Biotech Ltd.).
GEF Assay--
GEF activity of GST-frabin DH/PH and GST-Dbl was
assayed by measuring the radioactivity of [3H]GDP bound
to each lipid-modified small G protein (20 nM each) after
incubation at 30 °C for 10 min in the presence or absence of an
indicated amount of Rho GDI as described previously (10).
Assay for JNK Activity--
JNK activity was assayed as
described previously (7, 13). Briefly, pSR Other Procedures--
Immunofluorescence microscopy of cultured
COS7 cells and hippocampal neurons were done as described (7, 11).
Protein concentrations were determined with bovine serum albumin as a reference protein (18). SDS-polyacrylamide gel electrophoresis was done
as described previously (19).
GEF Activity of Frabin on Cdc42 and Its Responsible
Domain--
FGD1 has been described to show GEF activity on Cdc42Hs,
but not on Rac1 or RhoA (9). The domains responsible for this activity
of FGD1 are DHD and first PHD (9). We first examined whether a GST
fusion protein of frabin containing only these domains (GST-frabin
DH/PH) shows GEF activity on Cdc42Hs. GST-frabin DH/PH showed GEF
activity on Cdc42Hs in a dose-dependent manner (Fig. 1A). GST-Dbl also showed this
activity as described (10), but the efficiency of GST-frabin DH/PH on
Cdc42Hs activation was about 1.6% that of GST-Dbl (data not shown).
GST-frabin DH/PH was inactive on RhoA and Rac1 under the conditions
where GST-Dbl was active on all the three Rho family members (Fig.
1B). This result is consistent with the properties of FGD1
described previously (9). It has been shown that PHD binds acidic
phospholipids, such as PIP2 (20). We examined the effect of
PIP2 on GEF activity of frabin on Cdc42Hs. However,
addition of various doses of PIP2 (0-20 µM)
did not affect the activity of GST-frabin DH/PH (data not shown). It is
not known at present why GEF activity of frabin is very low, but an
unidentified factor(s) may enhance the activity.
Rho GDI is a general regulator of all the Rho family members (4). We
have previously shown that Rho GDI inhibits GEF activity of GST-Dbl on
RhoA, Rac1, and Cdc42Hs (10). Similarly, Rho GDI inhibited GEF activity
of GST-frabin DH/PH on Cdc42Hs in a dose-dependent manner
(Fig. 1C).
Domains of Frabin for Microspike Formation--
We then determined
the domains of frabin responsible for microspike formation in COS7
cells. We constructed the Myc-tagged, full-length and various fragments
of frabin which contained various combinations of each domain (Fig.
2A). Each Myc-tagged protein was transiently expressed in COS7 cells and cell shape was analyzed by
F-actin staining using fluorescent phalloidin. Consistent with our
previous observation in Swiss 3T3 cells (7), full-length frabin
(Myc-frabin-a) induced the formation of F-actin-containing microspikes
at the periphery of cultured COS7 cells (Fig. 2, B and
C). The microspikes were apparently similar to those induced by a dominant active mutant of Cdc42Hs (V12Cdc42Hs). To determine whether the frabin-induced microspikes were filopodia or retraction fibers, GFP-tagged, full-length frabin was transiently expressed in
COS7 cells. Time-lapse phase-contrast microscopy of the expressing cells revealed that most microspikes were filopodia, but some of them
were retraction fibers, consistent with an earlier observation with
Cdc42Hs-induced microspikes (21) (data not shown). The fragment lacking
ABD (Myc-frabin-c) induced the accumulation of F-actin at the cell
periphery, but it did not induce microspike formation. Neither the
fragment containing ABD alone (Myc-frabin-b) nor the fragment
containing DHD and first PHD (Myc-frabin-d) induced microspike
formation. The fragment containing ABD, DHD, and first PHD
(Myc-frabin-e) induced microspike formation. Consistent with our
previous observation (7), full-length frabin (Myc-frabin-a) and the
fragments having ABD (Myc-frabin-b and -e) were colocalized with
F-actin whereas the fragments lacking ABD (Myc-frabin-c and -d) showed
diffuse distribution throughout the cytoplasm. These results indicate
that ABD in addition to DHD and first PHD is necessary for microspike
formation.
Domains of Frabin for JNK Activation--
We have shown previously
that full-length frabin induces JNK activation to an extent about 40%
that induced by V12Cdc42Hs (7). We next analyzed the domains
responsible for this activity. We coexpressed a fragment of frabin
containing various combinations of each domain with HA-tagged JNK in
COS7 cells. The expressed JNK was immunoprecipitated and its kinase
activity toward GST-c-Jun was assayed. The fragment of frabin lacking
ABD (Myc-frabin-c) induced JNK activation to the extent similar to that
induced by full-length frabin (Myc-frabin-a) (Fig.
3, A and B).
Neither the fragment containing ABD alone (Myc-frabin-b), the fragment
containing DHD and first PHD (Myc-frabin-d), nor the fragment
containing ABD, DHD, and first PHD (Myc-frabin-e) was active in this
activity. These results indicate that DHD and first PHD are necessary
not only for microspike formation but also for JNK activation, but that
CRD and second PHD are additionally necessary for JNK activation.
Subcellular Localization and Tissue Distribution of Frabin--
We
analyzed the localization of frabin in growth cones of cultured rat
hippocampal neurons in which filopodia are markedly formed.
Immunofluorescence microscopy showed that frabin was highly concentrated at filopodia and poorly detected at lamellipodia (Fig.
4A). We then examined tissue
distribution of frabin in various rat adult tissues. Northern and
Western blot analyses showed that frabin was expressed in all the
tissues examined (Fig. 4, B and C). Lung and
kidney showed strong signals on Northern blot analysis whereas brain
and liver showed strong signals on Western blot analysis. The reason
for this discrepancy is not known, but it may be due to the difference
of the stability of frabin protein in various tissues. Two bands were
detected on Western blot analysis. The exact relationship between these
two bands remains to be clarified, but they may be splicing variants or
posttranslationally modified forms, such as the phosphorylated
form.
We have shown here that frabin shows GEF activity specific for
Cdc42 as described for FGD1 (9). Like other GEFs for the Rho family
members, frabin as well as FGD1 has both DHD and its adjacent PHD. The
aa sequences of these domains of many GEFs for the Rho family members
thus far identified are highly homologous. The aa sequences of DHD and
its adjacent PHD of frabin show 26% and 23% identity to those of Dbl,
respectively. However, those between frabin and FGD1 are more highly
homologous than those among other GEFs: the aa sequences of DHD and its
adjacent PHD of frabin show 71% and 57% identity to those of FGD1,
respectively. Of the many GEFs for the Rho family members, only frabin
and FGD1 are specific for Cdc42. It is likely that some specific region in these domains of frabin and FGD1 determines the specificity for
Cdc42, but it remains unknown how each GEF determines their substrate specificity.
We have then analyzed here the role of ABD of frabin in microspike
formation and JNK activation and shown that ABD is additionally necessary for microspike formation but not for JNK activation. In our
previous (7) and present report, we have furthermore shown that
full-length frabin (Myc-frabin-a) is associated with the actin
cytoskeleton in intact cells and that the fragment of frabin lacking
ABD (Myc-frabin-c) is diffusely distributed throughout the cytoplasm.
Myc-frabin-c contains DHD and first PHD which are capable of activating
Cdc42 in a cell-free system. This fragment of frabin is indeed active
in intact cells, because it induces JNK activation. However,
Myc-frabin-c is unable to induce microspike formation. It is likely
that Cdc42 activation in the vicinity of the actin cytoskeleton is
essential for reorganization of the actin cytoskeleton followed by
microspike formation. It has been shown that a fragment of FGD1
containing only DHD and first PHD induces microspike formation through
Cdc42 activation when microinjected into Swiss 3T3 cells (9, 22). It is
not known why there is the difference in the ability of microspike
formation between the similar fragments of FGD1 and frabin, but this
difference may be due to experimental conditions: In the FGD1
experiments, Swiss 3T3 cells were used and the protein or cDNA
samples were microinjected, whereas in our experiments, COS7 cells were
used and the cDNA samples were transfected. However, it could be
concluded, at least from these two experiments, that ABD is necessary
for more efficient microspike formation.
In contrast, the association of frabin with the actin cytoskeleton is
not essential for JNK activation. Of course, in intact cells,
full-length frabin is associated with the actin cytoskeleton and
activates Cdc42 around there, which then induces both microspike formation and JNK activation. It may be noted that the fragment of
frabin lacking ABD (Myc-frabin-c) is active but the fragment of frabin
containing only DHD and first PHD (Myc-frabin-d) is inactive for JNK
activation. It is not known whether this fragment is capable of
activating Cdc42 in intact cells, but these results suggest that ABD,
CRD, and second PHD intramolecularly or intermolecularly affect the
conformation of DHD and first PHD of frabin which determines GEF activity.
We have shown here that frabin is expressed in all the tissues thus far
examined, but the protein is most abundant in brain and liver. The
tissue distribution of frabin on Northern blot analysis is different
from that of FGD1 which is expressed in heart, brain, lung, and
skeletal muscle (8). We have moreover shown that frabin is localized at
filopodia at least in growth cones of cultured neurons. It is not known
how frabin is highly concentrated at filopodia, but this localization
is consistent with its ability to induce microspike formation through
Cdc42 activation. Frabin which is associated with the cortical actin cytoskeleton activates Cdc42, which then reorganizes the actin cytoskeleton to induce filopodium formation. Repetition of this process
may lengthen the microspike. In other words, the frabin-Cdc42 system
reorganizes the pre-existing actin cytoskeleton to a new structure.
Further study is necessary to clarify how frabin is localized at
filopodia and how it is activated there for our understanding of the
mechanisms of microspike formation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-HA-JNK
and GST-c-Jun
(13) were kindly supplied by Dr. E. Nishida (Kyoto University, Kyoto,
Japan). pEF-BOS-Myc-V12Cdc42Hs was prepared as described previously
(14). Phosphatidylinositol 4,5-diphosphate (PIP2) was
purchased from Sigma.
-HA-JNK
was transfected
with various pCMV-Myc constructs of frabin or pEF-BOS-Myc-V12Cdc42Hs in
COS7 cells using the DEAE-dextran method (17). After incubation for
16 h in serum-starved Dulbecco's modified Eagle's medium, the
cell lysates were subjected to immunoprecipitation with the anti-HA
antibody. Each immunoprecipitate was then washed and used to assay the
phosphorylation of GST-c-Jun after incubation in the presence of
[32P]ATP. The phosphorylation was detected by
autoradiography and quantified using an image analyzer (Fujix
BAS-2000II).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (26K):
[in a new window]
Fig. 1.
GEF activity of frabin. A,
dose-dependent activity on Cdc42Hs. The dissociation of
[3H]GDP from lipid-modified Cdc42Hs was assayed by
incubation for 10 min with various doses of GST alone or GST-frabin
DH/PH.
, GST-frabin DH/PH;
, GST alone. B, GEF
activity specific for Cdc42Hs. The dissociation of
[3H]GDP from each lipid-modified small G protein was
assayed by incubation for 10 min with 300 nM GST-frabin
DH/PH, 5 nM GST-Dbl, or 300 nM GST alone.
Hatched box, GST-frabin DH/PH; closed box,
GST-Dbl; and open box, GST alone. C,
inhibition of GEF activity by Rho GDI. The dissociation of
[3H]GDP from lipid-modified Cdc42Hs was assayed by
incubation for 10 min with 300 nM GST-frabin DH/PH or 5 nM GST-Dbl in the presence of various doses of Rho GDI.
, GST-frabin DH/PH;
, GST-Dbl.

View larger version (50K):
[in a new window]
Fig. 2.
Domains of frabin responsible for microspike
formation. A, structure of the full-length and various
fragment of frabin. B, immunofluorescence microscopy. COS7
cells were transfected with pEF-BOS-Myc-V12Cdc42Hs or various pCMV-Myc
constructs of frabin. The cells were doubly stained with the anti-Myc
antibody and rhodamine-phalloidin. Bars, 20 µm.
C, statistical analysis of microspike formation. The
activity of microspike formation was represented by the percentage of
cells with microspikes in cells positive for the Myc staining. The
cells with microspikes were defined as cells with F-actin-containing
thin protrusions (number of more than 10) at the cell periphery. Data
shown represent means ± S.D. of three independent experiments.
About 200 cells positive for the Myc staining were analyzed in each
experiment.

View larger version (38K):
[in a new window]
Fig. 3.
Domains of frabin for JNK activation.
A, phosphorylation of c-Jun. COS7 cells were transfected
with pSR
-HA-JNK
along with pEF-BOS-Myc-V12Cdc42Hs or various
pCMV-Myc constructs of frabin. pCMV-Myc vector was used as a control.
HA-tagged JNK was then immunoprecipitated with the anti-HA antibody. A
comparable amount of each immunoprecipitate was subjected to the assay
for JNK activity using GST-c-Jun as a substrate. The phosphorylation of
GST-c-Jun was detected by autoradiography. B, statistical
analysis of JNK activation. The phosphorylation of GST-c-Jun was
expressed as fold activation relative to the level of the
phosphorylation with the pCMV-Myc vector control. Data shown represent
means ± S.D. of three independent experiments.

View larger version (49K):
[in a new window]
Fig. 4.
Subcellular localization and tissue
distribution of frabin. A, localization in primary
cultured rat hippocampal neurons. The hippocampal neurons (2 days in
culture) were stained with the anti-frabin antibody.
Arrow, growth cone; arrowhead, cell
body. Inset a, staining of the inset b with
rhodamine-phalloidin. Bar, 20 µm. B, Northern
blot analysis. A RNA blot membrane (CLONTECH) was
hybridized with 32P-labeled, 1.2-kilobase pair
BamHI-XbaI fragment of the frabin cDNA
according to the manufacturer's protocol. C, Western blot
analysis. The homogenates of various rat tissues (20 µg of protein
each) were subjected to SDS-polyacrylamide gel electrophoresis (10%
polyacrylamide gel), followed by Western blot analysis with the
anti-frabin antibody. Lanes 1, heart; lanes 2,
brain; lanes 3, spleen; lanes 4, lung;
lanes 5, liver; lanes 6, skeletal muscle;
lanes 7, kidney; and lanes 8, testis.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. E. Nishida (Kyoto University,
Kyoto, Japan) for providing us with the GST-c-Jun and pSR
-HA-JNK
.
| |
FOOTNOTES |
|---|
* The work performed at Osaka University Medical School was supported by grants-in-aid for Scientific Research and for Cancer Research from the Ministry of Education, Science, Sports, and Culture, Japan (1998) and by grants from the Human Frontier Science Program (1998).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ The first and second authors contributed equally to the experimental work.
Present address: Eisai Company, Ltd., Tsukuba Research
Laboratories, Dept. of Drug Discovery, 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.

To whom correspondence should be addressed: Dept. of Molecular
Biology and Biochemistry, Osaka University Medical School, Suita
565-0871, Osaka, Japan. Tel.: 81-6-6879-3410; Fax: 81-6-6879-3419; E-mail: ytakai@molbio.med.osaka-u.ac.jp.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: G protein, GTP-binding protein; GEF, GDP/GTP exchange factor; DHD, Dbl homology domain; aa, amino acid; PHD, pleckstrin homology domain; F-actin, actin filament; ABD, F-actin-binding domain; CRD, cysteine-rich domain; JNK, c-Jun N-terminal kinase; GST, glutathione S-transferase; GDI, GDP dissociation inhibitor; HA, hemagglutinin; PIP2, phosphatidylinositol 4,5-diphosphate; GFP, green fluorescent protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Pollard, T. D., and Cooper, J. A. (1986) Annu. Rev. Biochem. 55, 987-1035[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Gumbiner, B. M. (1996) Cell 84, 345-357[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Lauffenburger, D. A., and Horwitz, A. F. (1996) Cell 84, 359-369[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Takai, Y., Sasaki, T., Tanaka, K., and Nakanishi, H. (1995) Trends Biochem. Sci. 20, 227-231[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Hall, A.
(1998)
Science
279,
509-514 |
| 6. | Symons, M. (1996) Trends Biochem. Sci. 21, 178-181[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Obaishi, H.,
Nakanishi, H.,
Mandai, K.,
Satoh, K.,
Satoh, A.,
Takahashi, K.,
Miyahara, M.,
Nishioka, H.,
Takaishi, K.,
and Takai, Y.
(1998)
J. Biol. Chem.
273,
18697-18700 |
| 8. | Pasteris, N. G., Cadle, A., Logie, L. J., Porteous, M. E. M., Schwartz, C. E., Stevenson, R. E., Glover, T. W., Wilroy, R. S., and Gorski, J. L. (1994) Cell 79, 669-678[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Zheng, Y.,
Fischer, D. J.,
Santos, M. F.,
Tigyi, G.,
Pasteris, N. G.,
Gorski, J. L.,
and Xu, Y.
(1996)
J. Biol. Chem.
271,
33169-33172 |
| 10. | Yaku, H., Sasaki, T., and Takai, Y. (1994) Biochem. Biophys. Res. Commun. 198, 811-817[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Nakanishi, H.,
Obaishi, H.,
Satoh, A.,
Wada, M.,
Mandai, K.,
Satoh, K.,
Nishioka, H.,
Matsuura, Y.,
Mizoguchi, A.,
and Takai, Y.
(1997)
J. Cell Biol.
139,
951-961 |
| 12. |
Yamochi, W.,
Tanaka, K.,
Nonaka, H.,
Maeda, A.,
Musha, T.,
and Takai, Y.
(1994)
J. Cell Biol.
125,
1077-1093 |
| 13. |
Moriguchi, T.,
Kuroyanagi, N.,
Yamaguchi, K.,
Gotoh, Y.,
Irie, K.,
Kano, T.,
Shirakabe, K.,
Muro, Y.,
Shibuya, H.,
Matsumoto, K.,
Nishida, E.,
and Hagiwara, M.
(1996)
J. Biol. Chem.
271,
13675-13679 |
| 14. | Komuro, R., Sasaki, T., Takaishi, K., Orita, S., and Takai, Y. (1996) Genes Cells 1, 943-951 [Abstract] |
| 15. | Guan, K. L., and Dixon, J. E. (1991) Anal. Biochem. 192, 262-267[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Press, Cold Spring Harbor, NY |
| 17. |
Hata, Y.,
and Südhof, T. C.
(1995)
J. Biol. Chem.
270,
13022-13028 |
| 18. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Harlan, J. E., Hajduk, P. J., Yoon, H., and Fesik, S. W. (1994) Nature 371, 168-170[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Kozma, R., Ahmed, S., Best, A., and Lim, L. (1995) Mol. Cell. Biol. 15, 1942-1952[Abstract] |
| 22. |
Nagata, K.,
Driessens, M.,
Lamarche, N.,
Gorski, J. L.,
and Hall, A.
(1998)
J. Biol. Chem.
273,
15453-15457 |
This article has been cited by other articles:
![]() |
F. L. Robinson, I. R. Niesman, K. K. Beiswenger, and J. E. Dixon Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice PNAS, March 25, 2008; 105(12): 4916 - 4921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hisata, T. Sakisaka, T. Baba, T. Yamada, K. Aoki, M. Matsuda, and Y. Takai Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes, leading to sustained activation of Rap1 and ERK and neurite outgrowth J. Cell Biol., August 27, 2007; 178(5): 843 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamada, T. Sakisaka, S. Hisata, T. Baba, and Y. Takai RA-RhoGAP, Rap-activated Rho GTPase-activating Protein Implicated in Neurite Outgrowth through Rho J. Biol. Chem., September 23, 2005; 280(38): 33026 - 33034. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Taira, M. Umikawa, K. Takei, B.-E. Myagmar, M. Shinzato, N. Machida, H. Uezato, S. Nonaka, and K.-i. Kariya The Traf2- and Nck-interacting Kinase as a Putative Effector of Rap2 to Regulate Actin Cytoskeleton J. Biol. Chem., November 19, 2004; 279(47): 49488 - 49496. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huang, K. Jacobson, and M. D. Schaller MAP kinases and cell migration J. Cell Sci., September 15, 2004; 117(20): 4619 - 4628. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukuhara, K. Shimizu, T. Kawakatsu, T. Fukuyama, Y. Minami, T. Honda, T. Hoshino, T. Yamada, H. Ogita, M. Okada, et al. Activation of Cdc42 by trans interactions of the cell adhesion molecules nectins through c-Src and Cdc42-GEF FRG J. Cell Biol., August 2, 2004; 166(3): 393 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Machida, M. Umikawa, K. Takei, N. Sakima, B.-E. Myagmar, K. Taira, H. Uezato, Y. Ogawa, and K.-i. Kariya Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 as a Putative Effector of Rap2 to Activate the c-Jun N-terminal Kinase J. Biol. Chem., April 16, 2004; 279(16): 15711 - 15714. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Samaj, F. Baluska, and H. Hirt From signal to cell polarity: mitogen-activated protein kinases as sensors and effectors of cytoskeleton dynamicity J. Exp. Bot., January 2, 2004; 55(395): 189 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Souchet, E. Portales-Casamar, D. Mazurais, S. Schmidt, I. Leger, J.-L. Javre, P. Robert, I. Berrebi-Bertrand, A. Bril, B. Gout, et al. Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere J. Cell Sci., January 2, 2002; 115(3): 629 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Estrada, E. Caron, and J. L. Gorski Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane Hum. Mol. Genet., March 1, 2001; 10(5): 485 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takai, T. Sasaki, and T. Matozaki Small GTP-Binding Proteins Physiol Rev, January 1, 2001; 81(1): 153 - 208. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |